Company / R&D Expense
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$2.3M
FY2025
5-year range
$0 / $6.3M
FY2021-FY2025
Trend
-5.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $6M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +174.6%.
Declined from $6M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +174.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +174.6%, indicating consistent growth.
- In FY2025, r&d expense decreased 5.9% year-over-year.
- Peak r&d expense was recorded in FY2023.
- Lowest r&d expense in the period was in FY2021.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | -5.9% |
| FY2024 | $2.4M | -61.7% |
| FY2023 | $6.3M | +5641.8% |
| FY2022 | $109.2K | - |
| FY2021 | $0 | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $96.6K | -62.9% |
| FY2018 | $260.1K | +204.8% |
| FY2017 | $85.3K | +0.0% |
| FY2016 | $85.3K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026